The mammalian SWI/SNF, or BAF complex, has a conserved and direct role in antagonizing polycomb-10 mediated repression. Yet, BAF appears to also promote repression by polycomb in stem cells and cancer. 11
Introduction

25
Chromatin regulation is critical to establish and maintain the precise gene expression states that define 26 cellular identity and prevent human pathologies (Flavahan et al., 2017) . The balance between different 27 states primarily involves the antagonism between activating (Trithorax-group) and repressive (Polycomb-28 group) proteins (Schuettengruber et al., 2017) . Opposition between these two classes of chromatin 29 regulators was first demonstrated genetically during Drosophila development (Kingston and Tamkun, 30 2014) . For example, deletion of Polycomb-group genes results in Hox gene derepression which gives rise 31 to homeotic transformations, whereas Trithorax-group mutations dominantly suppress these phenotypes 32 (Kennison and Tamkun, 1988; Tamkun et al., 1992) . Similarly, loss of function mutations in Trithorax-33 group genes also produce homeotic transformations but are instead due to insufficient Hox gene 34 expression (Capdevila et al 1981) . Following these pioneering studies, the genes encoding members of 35 these groups have been shown to be mutated in many human diseases. This is especially true for the BAF 36 (mSWI/SNF) complex, a Trithorax-group homolog, which is frequently mutated in many cancers, 37 neurodevelopmental disorders, and intellectual disabilities (Kadoch and Crabtree, 2013; Ronan et al., 38 2013; Shain and Pollack, 2013) . 39 BAF complexes are combinatorially assembled chromatin remodeling enzymes of ~15 subunits that 40 hydrolyze ATP to mobilize nucleosomes and generate accessible DNA (Clapier et al., 2017) . In 41 mammalian cells, BAF directly evicts both polycomb repressive complexes (PRC) 1 and 2 (Kadoch et al., 42 2017; Stanton et al., 2017) leading to transcriptional derepression (Braun et al., 2017) . Thus, the ability of 43
Trithorax-group proteins to antagonize polycomb-mediated repression is conserved from Drosophila to 44 mammals. PRC1 and PRC2 direct H2A ubiquitination (H2AK119ub1) and trimethylation of histone H3 45 at lysine 27 (H3K27me3) respectively and spatially constrain the genome in support of transcriptional 46 repression (Schuettengruber et al., 2017) . BAF-mediated polycomb antagonism is essential during 47 development and is thought to underlie the tumor suppressive role in human cancers (Valencia and 48 Kadoch, 2019) . Conversely, BAF's potent ability to antagonize polycomb-mediated repression is coopted 49 in synovial sarcoma, where translocation of SSX onto the SS18 subunit retargets BAF and opposes 50 polycomb-mediated repression to drive tumor growth (Kadoch and Crabtree, 2013; McBride et al., 2018) . 51
Despite extensive evidence that BAF has a dominant role in polycomb opposition, BAF appears to also 52 be required for polycomb-mediated repression in embryonic stem cells, during lineage commitment, and 53 in sub-types of rare atypical teratoid rhabdoid tumors (ATRT) tumors that are typically seen in children younger than 3. These tumors are characterized by inactivation 56 of either BAF47 or Brg1, the core ATPase subunit, and rarely contain mutations in other genes (Masliah-57 Planchon et al., 2015; Nakayama et al., 2017) . Currently, the mechanism by which BAF can 58 simultaneously support active and repressed states remains unknown. 59
A major limitation to resolving this question has been with loss of function approaches that lack sufficient 60 temporal resolution. Chromatin remodeling complexes like BAF regulate accessibility for virtually all 61 DNA-based processes and have many ascribed roles from transcriptional regulation to cell division. 62
Additionally, chromatin regulators tend to be stable for several days following conditional deletion or 63 knockdown and are subject to feedback mechanisms, making it impossible to determine whether 64 transcriptional effects are primary or secondary. To overcome these limitations, we implemented a 65 chemical genetic approach to enable rapid targeted protein degradation of BAF, PRC1, and PRC2 in 66 mouse embryonic stem cells (mESCs). We demonstrate that BAF inactivation results in the genome-wide 67 redistribution of PRC1 & 2 on the timescale of hours, from highly occupied domains like Hox clusters, to 68 sites that are normally lowly occupied. Moreover, we demonstrate through both dose-dependent 69 degradation of PRC1&2 and PRC1 overexpression that insufficient polycomb dosage underlies these 70 effects. Collectively, our study reveals that BAF titrates the dosage of PRC1&2 complexes on chromatin, 71 reconciling the dual role for BAF in opposition and maintenance of polycomb-mediated repression. 72
Results
73
Brg1 degradation with auxin is rapid and near complete 74
To temporally resolve the downstream effects of BAF inactivation we developed an ESC line where the 75 core ATPase subunit Brg1 (also known as Smarca4) can be rapidly degraded. Both endogenous alleles of 76 Brg1 were tagged with the minimal 44 amino acid auxin inducible degradation tag (AID*) using CRISPR-77
Cas9 with homology-dependent repair (Morawska and Ulrich, 2013; Nishimura et al., 2009) 78 ( Supplementary Fig 1A,B) . The F-box protein osTIR1 was inducibly expressed in these cells, which forms 79 a hybrid SCF ubiquitin ligase complex that targets Brg1 for degradation by the proteasome when the small 80 molecule auxin is added ( Figure 1A ). Tagging Brg1 with AID* did not affect protein abundance, such that 81 for all experiments Brg1 levels were equivalent to WT before the addition of auxin ( Figure 1B ). 82
Additionally, these cells divide at the same rate and appeared indistinguishable from the parent mESC 83 line. Consistent with other studies, auxin addition in the absence of osTIR1 was innocuous to cell viability 84 and growth (Nora et al., 2017 ). Yet, when auxin was added to cells expressing osTIR1, Brg1 was rapidly 85 degraded, with a protein half-life of ~30 minutes and maximal, near-complete, degradation was achieved 86 by 2 hours ( Figure 1C) . A degron approach enables much faster loss of function compared to genetic 87 deletion which takes ~3 days for comparable protein depletion. This induces much faster disruption to 88 colony morphology and a reduction in peripheral alkaline phosphatase staining at 24h, indicative of 89 compromised pluripotency ( Figure 1D , and Supplementary Figure 1C) . Thus, the Brg1 degron is a 90 tractable and robust strategy to resolve the effects of BAF inactivation on the timescale of hours. 91 92
Brg1 degradation results in the derepression of many highly polycomb bound genes 93
Previous studies have shown that genetic deletion or knockdown of Brg1 results in differential expression 94 of many genes after 3-4 days (Ho et Figure 2C) , suggesting that rapid 121 depletion captured a distinct, more direct effect from other approaches. Thus, Brg1 degradation induces 122 quick transcriptional changes, both up and down, that progressively increase in magnitude over the time-123 course, consistent with being directly regulated by BAF. 124
We were surprised to find that many of the most strongly derepressed genes colocalized with major PRC1 125 and PRC2 peaks with the highest occupancy on the chromosome ( Figure 2C ). Many Polycomb-group 126 target genes in ES cells have roles in neural development (Boyer et al., 2006) . Consistent with this, 127 upregulated genes were strongly enriched for neural differentiation genes and neural transcription factors 128 (Supplementary Figure 2D) . Hox A, B, and D genes were amongst the most strongly derepressed (up to 129 ~440 fold by 24h) and showed a clear time-dependent increase in transcription upon Brg1 degradation 130 with changes seen as early as the 2-hour time-point ( Figure 2D , E). Previous studies have shown that some 131 of these sites form extra long-range chromosomal interactions that require PRC1, (indicated by dashed 132 arrows in Fig 2C) , for example between HoxD and Bmi1, Pax6, Meis2, and Lmx1b. These contacts are 133 lost when cells are switched to 2i media, resembling a more naïve pluripotent state that is less reliant on 134 polycomb-mediated repression (Joshi et al., 2015) . We compared Brg1 degron mediated derepression in 135 2i vs serum conditions and found that the effect was much stronger in serum (~3 to 16 fold for Hox genes) 136 consistent with compromised polycomb-mediated repression driving the transcriptional derepression 137
(Supplementary Figure 2E) . 138
Collectively, these results suggest that BAF directly facilitates polycomb-mediated repression. Consistent 139 with this model, we found that many genes that were derepressed by Brg1 degradation were also 140 derepressed upon knockout of PRC1&2 (349 of 788) (King et al., 2018 ). In addition, these genes showed 141 genes are differentially expressed, we found a negative correlation between polycomb occupancy and 147 differential expression upon Brg1 degradation. Genes that were lowly bound by polycomb (Ring1b or  148 Suz12 peaks +/-2kb from the TSS, ntiles 1 and 2) became repressed, whereas genes with the highest 149 polycomb levels (ntile 3) were derepressed by Brg1 degradation ( Figure 2F , P < 0.05 between ntiles 1,2 150 and 3 for both Ring1b and Suz12 We next sought to determine the effect of Brg1 degradation on PRC1&2 occupancy genome-wide by 155 conducting ChIP-seq for Ring1b and Suz12 (core components of PRC1 and PRC2 complexes) 156
( Supplementary Fig 3A) . of peaks changed for Ring1b and Suz12 respectively at FDR-corrected P < 0.1). Peaks with low Ring1b 160 and Suz12 occupancy were mostly increased (as assessed by normalized peak counts), whereas highly 161 occupied peaks mostly showed loss following 8h Brg1 degradation ( Figure 3A ). This general trend can 162 be seen in representative genome-browser snapshots of increased (Cyp2s1 and Ptk2b) and decreased 163 (HoxA/D clusters) sites ( Figure 3B ) (Supplementary Figure 3B , C). We next sought to better temporally 164 resolve this loss at heavily occupied loci, since it's currently unclear how BAF might promote polycomb-165 mediated repression at these sites. We conducted Ring1b ChIP-qPCR at additional time-points (4, 8, and 166 24h). All sites assayed showed significant loss by 4 hours, that decreased in a time-dependent manner 167 (~20-60% reduction), further supporting a direct time-dependent requirement on BAF activity 168 (Supplementary Figure 3D) . Collectively, these results demonstrate that the loss of PRC2 at Hox clusters 169 previously seen after 72h conditional deletion (Ho et al., 2011) occurs after only a few hours and revealed 170 that PRC1 is also lost. In fact, Brg1 degron induced changes to PRC1&2 were highly correlated across all 171 peaks (R = 0.79, p < 2.2e-16) and differentially bound peaks displayed a high degree of overlap ( Figure  172 3C,D). Importantly, these changes were independent of global changes to the histone modifications placed 173 by these complexes and the core proteins themselves even at much longer time-points (Supplementary 174 Figure 3E ). 175 176
Chromatin state enrichment analysis (Ernst and Kellis, 2012) revealed that PRC1&2 peaks were highly 177 enriched for bivalent chromatin, with slight enrichment for the repressed state in sites decreased upon 178
Brg1 degradation ( Figure 3E ). We wondered whether the high normalized peak counts seen at decreased 179 sites were due to enrichment for broader domains as a general principle, as seen for the Hox clusters, so 180
we plotted the peak width density for all, increased, and decreased peaks ( Figure 3F ). We found that the 181 increased peaks had a very similar distribution to all PRC1&2 peaks (Ring1b median for all peaks = 2.2kb, 182 increased = 2.3kb and Suz12 median for all peaks = 2.9kb, increased = 2.7kb), but decreased peaks 183 contained broader polycomb domains (Ring1b median decreased = 2.9kb, Suz12 median decreased = 184 4.7kb). We previously showed that the basal 185 occupancy level of PRC1&2 was predictive 186 of the direction of differential gene expression 187 when Brg1 was degraded ( Figure 2F ). Ring1b (R = -0.45, P < 2.2e-16 and R = -0.5, P < 2.2e-16) and Suz12 (R = -0.37, P < 2.2e-16 and R = -247 0.44, P < 2.2e-16) genome-wide ( Figure 5A ,B), such that loci with increased PRC1&2 had decreased 248 active marks ( Figure 5C ) and loci with decreased PRC1&2 had an increase 8h after Brg degradation 249 ( Figure 5D Figure 5I) . These results confirm that polycomb loss following Brg1 265 degradation is independent of transcription, which is consistent with the loss of polycomb across large 266 domains, not just near genes that become derepressed. 267
In general, BAF and PRC1&2 overlap extensively genome-wide, however highly occupied sites are 268 mutually exclusive for both ( Supplementary Fig 5C, D) . This suggests that BAF antagonizes polycomb at 269 weakly bound sites but is mostly excluded from highly bound sites, like Hox. To investigate this further, 270
we looked at accessibility changes by ATAC-seq that result from Brg1 depletion at sites where polycomb 271 changes (Miller et al., 2017) . Accessibility changes likely reflect the most accurate signature of SWI/SNF 272 chromatin remodeling activity since the readout is the endpoint of the catalytic cycle, i.e. nucleosome 273 eviction. We reasoned that if BAF generated accessibility that is required to load polycomb, then 274 accessibility changes should mimic polycomb changes. In sharp contrast to this, we actually found that 275 sites that lost polycomb become more accessible, and sites that gained polycomb become less accessible 276 ( Figure 5E , and Supplementary Figure 5C ). These changes in accessibility are attributed solely to BAF 277
ATPase activity, as polycomb deletion does not affect accessibility to Tn5 transposition in mESCs 278 (Hodges et al., 2018; King et al., 2018) . These results are most consistent with a model where BAF 279 facilitates polycomb-mediated repression through distant PRC1&2 eviction at abundant sites of low 280 polycomb affinity, allowing for accumulation at sites of apparent higher affinity, such as Hox genes. 281
282
PRC1&2 dosage sensitivity underlies the requirement for BAF in polycomb-mediated repression 283
If our model is correct and BAF acts by ATP-dependent eviction of polycomb from some regions, such 284 that it can accumulate at others, it implies that there must be insufficient polycomb to both accumulate 285 across the genome when BAF is depleted and maintain repression. To test this, we wanted a system where 286 we can rapidly degrade PRCs in a dose-dependent way and measure the degree of gene derepression 287 relative to Brg1 at the same time-point. For this goal, we used the dTAG targeted degradation approach, 288 which enables highly dose-dependent, specific, and efficient protein degradation (Nabet et al., 2018) . We 289 tagged endogenous alleles of essential subunits of PRC1 (Ring1b), PRC2 (EED), and both proteins in the 290 same cell line with the FKBP F36V tag that enables targeted degradation in the presence of dTAG13, an 291 heterobifunctional analog of rapamycin (Stanton et al., 2018) . EED, is required to maintain global levels 292 of H3K27me3 and to stabilize other subunits of the PRC2 complex (Montgomery et al., 2005) . Tagging 293 these proteins didn't noticeably affect protein abundance, cell viability, or growth ( Figure 6A ,B, 294 Supplementary Figure 6A, 
B). 296
We observed step-wise 297 near complete degradation 298 of EED using 10-fold serial 299 dilution of dTAG13 ligand 300 at 8h ( Figure 6C) Figure 6D bottom and 6F ). However, a few genes still exhibited stronger derepression in the 335 Brg1 degron than Ring1b, even upon near-complete Ring1b degradation ( Figure 6D , bottom). Our 336 previous ChIP-seq experiments revealed that Brg1 degradation results in the redistribution of both 337 PRC1&2, so we next sought to determine the effect of depleting both subunits in the same cell ( Figure  338 6E). We found that indeed, there was an additive effect of degrading Ring1b and EED on derepression, 339 with all genes exhibiting similar derepression as Brg1 at intermediate levels, and either stronger or the 340 same level upon maximal degradation ( Figure 6E, bottom) . These results demonstrate that complete loss 341 of PRC1&2 leads to stronger derepression than Brg1, however intermediate loss closely resembles the 342 Our studies demonstrate that targeted degradation of Brg1, the ATPase subunit of the BAF complex, 370 rapidly derepressed hundreds of strongly polycomb-repressed genes on the timescale of hours. 371 deregulation of a few genes, or cell death. Surprisingly, the magnitude of the transcriptional derepression 404 we observe is much stronger (up to ~40x higher) than was previously observed with conditional 405 knockouts, demonstrating that rapid degradation approaches are also less subject to secondary feedback 406 mechanisms. 407
Polycomb-mediated repression has long been known to be dosage sensitive, such that heterozygous 408 genetic deletion alters expression of Hox genes, giving rise to homeotic transformations (Kennison and  409 Tamkun, 1988). Intriguingly, most PRC genes themselves don't appear to be strongly dosage-sensitive in 410 human disease (Karczewski et al., 2019 ). An interesting conclusion from our work is that chromatin 411 regulators that antagonize binding, like BAF and possibly others, titrate the effective dosage of all 412
Polycomb complexes and could explain why many BAF subunits are strongly haploinsufficient in human 413 disease. Previously it was shown that PRC1 eviction by BAF was mediated by a direct ATP-dependent 414 interaction with Brg1 (Stanton et al., 2017) . Future studies are needed to define the role of other subunits 415 in polycomb antagonism. Nonetheless, our studies suggest that BAF activity is a major determinant of 416 polycomb dynamics in ES cells, which have a hypermobile polycomb fraction (Fonseca et al., 2012) . 417 Thus, it's possible that this dynamic state is especially sensitive to modulation on chromatin, as BAF has 418 been shown to facilitate polycomb-mediated repression in pluripotency, during lineage commitment, and 419 in pediatric brain tumors but not in more differentiated cells. 420
While individual BAF subunits are highly mutated in specific types of cancer, BAF is almost exclusively 421 mutated in neurodevelopmental disorders but not in other types of human disease (Kadoch and Crabtree,  422 2015). The underlying mechanism for this specificity remains unknown. Our results suggest an 423 explanation by which BAF's unique ability to modulate effective polycomb dosage on chromatin in 424 pluripotent cells that, in turn, leads to derepression of genes involved in neurogenesis. A possible 425 explanation for this specificity arises from the observation that the mRNA for certain posterior Hox genes 426 such as Hoxd10 increase by 400-fold upon BAF degradation. This would cause the embryo with a 427 mutation in the BAF complex to enter neurogenesis with posterior hox genes expressed in developing 428 neural tissue. Based on murine studies this "hox confusion" would lead to temporally disordered patterns 429 of gene expression in neural progenitors and abnormal neural development (Philippidou and Dasen, 2013 ChIP experiments were performed essentially as described (Braun et al., 2017) . Briefly, at the end of the 497 time-point 30M cells were fixed with 1% formaldehyde for 12 min, quenched, and sonicated with a 498
Covaris focused ultrasonicator (~200-800bp). Sonicated chromatin was split into separate tubes (~5-10M 499 cell equivalent per IP) and incubated with 5µg primary antibody and 25µL protein G Dynabeads (Life 500
Technologies 10009D) overnight. Beads were washed 4 times and DNA was isolated for qPCR or library 501 preparation. Antibodies are listed in supplemental In preparation for imaging, mESC cells were plated on 40-mm glass coverslips (Bioptechs) coated with 533 0.1-0.2% Gelatin, and fixed on the following day in 4% PFA in 1xPBS for 10 min. The hybridization and 534 imaging were performed as previously described (Mateo et al. 2019) . Briefly, for primary probe 535 hybridization, cells were permeabilized for 10min with 0.5% Triton-X in 1xPBS, the DNA was then 536 denatured by treatment with 0.1M HCL for 5min. 2ug of primary probes in hybridization solution was 537 then added directly on to cells, placed on a heat block for 90C for 3min and incubated overnight at 42C in 538 a humidified chamber. Prior to imaging, the samples were post-fixed for 1h in 8%PFA +2% 539 glutaraldehyde (GA) in 1xPBS. The samples were then washed in 2xSSC and either imaged directly or 540 stored for up to a week in 4C prior to imaging. For imaging samples were mounted into a Bioptechs flow 541 chamber, and secondary probe hybridization and step by step imaging of individual barcodes, and image 542 processing was performed as in (Mateo et al., 2019) . 543 544
Image analysis was performed as described in (Mateo et al., 2019) . For all analysis in Figure 4 , we 545 excluded all barcodes that had a low labeling efficiency in either control or AID treated condition (labelled 546 in less than 10% of the cells control for sample size, we randomly split the cells in the control dataset into 2, calculated median of 557 pairwise probe distances for each subset and computed the difference in pairwise distances between the 558 two halves and between each control subset and Brg1 depleted cells (Supplemental Figure 4D , E). 559 560
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